1. Conservation de la succinylcholine en préhospitalier après recommandations de l'Agence nationale de santé et du médicament.
- Author
-
Lefort, H., Mendibil, A., Margerin, S., Cuquel, A.-C., Jost, D., Tazarourte, K., Domanski, L., and Tourtier, J.-P.
- Subjects
- *
SUCCINYLCHOLINE , *MEDICATION safety , *COMPUTER surveys , *ACQUISITION of data , *DECISION making , *DRUG laws - Abstract
Objective The French National Pharmaceuticals Agency (ANSM) has recommanded in July 2012 not to break the cold chain before using succinylcholine (Celocurine®). Research objective: to understand the pre-clinical evolution of the conservation modes of this curare. Research type Descriptive study before (year 2011) and after (year 2012). Patients and method Online survey to French Samu/Smur. Data collected: SMUR location, conservation method at clinical base, in the mobile unit (UMH) and at the patient. Principal decision criteria: evolution of the conservation modes before and after the recommendation (qualitatives variables compared with a Fisher test). Results Out of 101 SAMU/SMUR, 62 answered. Conservation modes of succinylcholine vials were significantly different (P < 0.001). Proper conservation was observed in 26 % of the cases before and 43 % after. Mobile units (UMH) equipped with a fridge increased from one out of two to 77 %. The lack of conservation modes passive or active on UMH went from 31 % to 3.4 % with isotherms bags with ice when a fridge was not available. The destruction of capsules at current temperature in a 24-hour period increased: 22 % before, 47 % after (P = 0.04). Conclusion After recommendations from ANSM, conservation modes and destruction of succinylcholine in a prehospital environment were significantly impacted. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF